California’s Obalon Therapeutics said it launched a pivotal trial set for as many as 15 sites across the U.S. that will test its ingestible, gas-filled weight-loss balloon.
Stryker debuts Osiris bone putty
FDA clears Stryker’s Lite lumbar plating system
InVivo adds 3rd site to clinical trial
Wright Medical wins FDA nod for Salvation external fixation device
IlluminOss launches U.S. trial for bone fracture device
AtriCure launches CryoIce treatment for pain
CardioNet overbills, BioTelemetry pays $6m
UPDATED April 3, 2015, with comment from BioTelemetry.
BioTelemetry Inc. agreed to fork over $6.4 million to settle federal charges that its CardioNet subsidiary overbilled Medicare for unnecessary outpatient services.